About
Therapeutic solutions for muco-obstructive lung diseases
Areas of Focus
Categories
Small Molecule PharmaceuticalNorth & South Carolina
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
172
By Phase
PHASE2: 1PHASE1: 1
By Status
NOT_YET_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06731959Lead Sponsor
A Study to Investigate Using Inhaled Fexlamose to Treat Adult Participants Who Have Moderate to Severe COPD
PHASE2Not yet recruiting
100 participants
Started: Dec 31, 2024 · Completed: Jan 31, 2026
NCT05862623Lead Sponsor
Single and Multiple Ascending Dose Study of AER-01
PHASE1Unknown
72 participants
Started: May 26, 2023 · Completed: Aug 31, 2024
Locations (1)
Headquarters
Raleigh, NC, United States
Map
Loading map...